CLINICAL_TRIALS
trial_result
· 2025-05-29
Clinical Trial Update: An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin [Phase 4]
Summary
Open-label Phase 4 extension assessing the continued efficacy of Omacor plus simvastatin in dyslipidemia; results were posted on 2025-05-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Provident Clinical Research | Conditions: Dyslipidemias | Phase 4 | Status: COMPLETED | Results posted: 2025-05-29